{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:11:55Z","timestamp":1758672715290,"version":"3.44.0"},"reference-count":28,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Retroperitoneal sarcoma is a rare malignancy, and surgical resection remains the primary treatment option. While neoadjuvant radiotherapy has shown limited long\u2010term benefits, the role of neoadjuvant chemotherapy in this setting remains uncertain. This study aimed to evaluate the impact of neoadjuvant chemotherapy on survival outcomes in patients with resectable retroperitoneal sarcoma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A comprehensive search was performed in PubMed, Scopus, the Central Register of Clinical Trials, and Web of Science for studies published up to December 2024. Hazard ratios (HRs) with 95% confidence intervals (CIs) were pooled using a random\u2010effects model, and heterogeneity was assessed using <jats:italic>I<\/jats:italic>\u00b2 statistics. Statistical analyses were conducted using R Software version 4.4.1 (R Foundation for Statistical Computing).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Four retrospective studies were included, comprising a total of 2156 patients with resectable retroperitoneal sarcoma, of whom 361 (16.7%) received neoadjuvant chemotherapy. The analysis showed no significant difference in 5\u2010year overall survival between patients who underwent neoadjuvant chemotherapy and those who did not. A sensitivity analysis, performed after excluding the study contributing most to heterogeneity, revealed a statistically significant 18% higher risk of mortality in patients receiving neoadjuvant chemotherapy (HR 1.18; 95% CI 1.06\u20131.32). Heterogeneity dropped to <jats:italic>I<\/jats:italic>\u00b2\u2009=\u20090% in this analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These findings suggest that neoadjuvant chemotherapy may be associated with worse survival outcomes, although these results remain exploratory due to the retrospective nature of the included studies and the limited number of available datasets. Ongoing prospective trials, such as the STRASS2 trial, will be critical to further defining the role of neoadjuvant chemotherapy in retroperitoneal sarcoma management.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jso.70037","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T12:34:23Z","timestamp":1752150863000},"page":"727-735","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neoadjuvant Chemotherapy for Retroperitoneal Sarcoma: A Systematic Review and Meta\u2010Analysis"],"prefix":"10.1002","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2960-3810","authenticated-orcid":false,"given":"Bernardo Fontel","family":"Pompeu","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology Heliopolis Hospital S\u00e3o Paulo Brazil"},{"name":"University of S\u00e3o Caetano do Sul S\u00e3o Paulo Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9215-2639","authenticated-orcid":false,"given":"Luiza Soares","family":"Guerra","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology Heliopolis Hospital S\u00e3o Paulo Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9321-2330","authenticated-orcid":false,"given":"Julia Hoici","family":"Brunini","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology Heliopolis Hospital S\u00e3o Paulo Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6086-4240","authenticated-orcid":false,"given":"Gabriel Leal","family":"Barone","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Caetano do Sul S\u00e3o Paulo Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7687-3073","authenticated-orcid":false,"given":"Lucas Monteiro","family":"Delgado","sequence":"additional","affiliation":[{"name":"Federal University of Minas Gerais Belo Horizonte Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3293-5420","authenticated-orcid":false,"given":"Maria Let\u00edcia Gobo","family":"Silva","sequence":"additional","affiliation":[{"name":"Sarcoma and Bone Tumors Reference Center \u2010 A.C. Camargo Cancer Center S\u00e3o Paulo Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7771-8059","authenticated-orcid":false,"given":"Fernando Augusto Batista","family":"Campos","sequence":"additional","affiliation":[{"name":"Sarcoma and Bone Tumors Reference Center \u2010 A.C. Camargo Cancer Center S\u00e3o Paulo Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3476-727X","authenticated-orcid":false,"given":"Samuel","family":"Aguiar Junior","sequence":"additional","affiliation":[{"name":"Sarcoma and Bone Tumors Reference Center \u2010 A.C. Camargo Cancer Center S\u00e3o Paulo Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"4","key":"e_1_2_10_2_1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jso.2930190410","article-title":"Results of The National Soft\u2010Tissue Sarcoma Registry","volume":"19","author":"Mettlin C.","year":"1982","journal-title":"Journal of Surgical Oncology"},{"issue":"1","key":"e_1_2_10_3_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1102\/1470-7330.2005.0019","article-title":"Retroperitoneal Sarcomas","volume":"5","author":"Francis I. R.","year":"2005","journal-title":"Cancer Imaging"},{"issue":"7","key":"e_1_2_10_4_1","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1245\/s10434-014-3616-7","article-title":"A Contemporary Large Single\u2010Institution Evaluation of Resected Retroperitoneal Sarcoma","volume":"21","author":"Bremjit P. J.","year":"2014","journal-title":"Annals of Surgical Oncology"},{"issue":"10","key":"e_1_2_10_5_1","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ejso.2015.07.014","article-title":"Impact of Chemotherapy on Survival in Surgically Resected Retroperitoneal Sarcoma","volume":"41","author":"Miura J. T.","year":"2015","journal-title":"European Journal of Surgical Oncology (EJSO)"},{"issue":"11","key":"e_1_2_10_6_1","doi-asserted-by":"crossref","first-page":"6886","DOI":"10.1245\/s10434-023-13933-2","article-title":"Neoadjuvant Chemotherapy in Retroperitoneal Sarcoma: A National Cohort Study","volume":"30","author":"Tortorello G. N.","year":"2023","journal-title":"Annals of Surgical Oncology"},{"issue":"11","key":"e_1_2_10_7_1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25529","article-title":"Evaluation of Preoperative Chemotherapy or Radiation and Overall Survival in Patients With Nonmetastatic, Resectable Retroperitoneal Sarcoma","volume":"3","author":"Ma S. J.","year":"2020","journal-title":"JAMA Network Open"},{"issue":"3","key":"e_1_2_10_8_1","first-page":"100","article-title":"A Ten Year Review Of Management and Outcomes Of Retroperitoneal Sarcoma: A Retrospective Cohort Study","volume":"93","author":"McKinley N.","year":"2024","journal-title":"Ulster Medical Journal"},{"key":"e_1_2_10_9_1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.856754","article-title":"Prognostic Factors and Nomogram Construction for First Local Recurrent Retroperitoneal Sarcoma Following Surgical Resection: A Single Asian Cohort of 169 Cases","volume":"12","author":"Zhuang A.","year":"2022","journal-title":"Frontiers in Oncology"},{"issue":"2","key":"e_1_2_10_10_1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00000658-199502000-00009","article-title":"Prognostic Factors Predictive of Survival for Truncal and Retroperitoneal Soft\u2010Tissue Sarcoma","volume":"221","author":"Singer S.","year":"1995","journal-title":"Annals of Surgery"},{"issue":"2","key":"e_1_2_10_11_1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.sla.0000108670.31446.54","article-title":"Operative Management of Primary Retroperitoneal Sarcomas: A Reappraisal of an Institutional Experience","volume":"239","author":"Hassan I.","year":"2004","journal-title":"Annals of Surgery"},{"issue":"3","key":"e_1_2_10_12_1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/archsurg.138.3.248","article-title":"Retroperitoneal Sarcomas: Grade and Survival","volume":"138","author":"Ferrario T.","year":"2003","journal-title":"Archives of Surgery"},{"issue":"1","key":"e_1_2_10_13_1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.radonc.2013.10.041","article-title":"Combined Management of Retroperitoneal Sarcoma With Dose Intensification Radiotherapy and Resection: Long\u2010Term Results of a Prospective Trial","volume":"110","author":"Smith M. J. F.","year":"2014","journal-title":"Radiotherapy and Oncology"},{"issue":"1","key":"e_1_2_10_14_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1200\/JCO.2008.18.0802","article-title":"Primary Retroperitoneal Sarcomas: A Multivariate Analysis of Surgical Factors Associated With Local Control","volume":"27","author":"Bonvalot S.","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30446-0"},{"issue":"1","key":"e_1_2_10_16_1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/SLA.0000000000005492","article-title":"Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma: EORTC\u201062092 Trial (STRASS) Versus Off\u2010Trial (STREXIT) Results","volume":"278","author":"Callegaro D.","year":"2023","journal-title":"Annals of Surgery"},{"issue":"5","key":"e_1_2_10_17_1","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/SLA.0000000000001447","article-title":"Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi\u2010Institutional Collaborative RPS Working Group","volume":"263","author":"Gronchi A.","year":"2016","journal-title":"Annals of Surgery"},{"issue":"8","key":"e_1_2_10_18_1","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1245\/s10434-023-13500-9","article-title":"A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients With High\u2010Risk Retroperitoneal Sarcoma (STRASS2)","volume":"30","author":"Lambdin J.","year":"2023","journal-title":"Annals of Surgical Oncology"},{"issue":"19","key":"e_1_2_10_19_1","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1200\/JCO.2000.18.19.3378","article-title":"Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity in Soft Tissue Sarcomas","volume":"18","author":"Meric F.","year":"2000","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"e_1_2_10_20_1","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1245\/s10434-006-9255-x","article-title":"Retroperitoneal and Truncal Sarcomas: Prognosis Depends Upon Type Not Location","volume":"14","author":"Perez E. A.","year":"2007","journal-title":"Annals of Surgical Oncology"},{"key":"e_1_2_10_21_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102663","article-title":"A Systematic Review of the Role of Chemotherapy in Retroperitoneal Sarcoma by the Australia and New Zealand Sarcoma Association Clinical Practice Guidelines Working Party","volume":"122","author":"Zhou D. D. X.","year":"2024","journal-title":"Cancer Treatment Reviews"},{"key":"e_1_2_10_22_1","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The Prisma 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page M. J.","year":"2021","journal-title":"BMJ"},{"key":"e_1_2_10_23_1","article-title":"Neoadjuvant Chemotherapy for Retroperitoneal Sarcoma: A Systematic Review and Meta\u2010Analysis","author":"Pompeu B. F.","year":"2024","journal-title":"PROSPERO"},{"key":"e_1_2_10_24_1","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS\u2010I: A Tool for Assessing Risk of Bias in Non\u2010Randomised Studies of Interventions","volume":"355","author":"Sterne J. A.","year":"2016","journal-title":"BMJ"},{"issue":"11","key":"e_1_2_10_25_1","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying Heterogeneity in a Meta\u2010Analysis","volume":"21","author":"Higgins J. P. T.","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"1","key":"e_1_2_10_26_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12893-019-0521-9","article-title":"Analysis of Outcomes and Predictors of Long\u2010Term Survival Following Resection for Retroperitoneal Sarcoma","volume":"19","author":"Malinka T.","year":"2019","journal-title":"BMC Surgery"},{"issue":"5","key":"e_1_2_10_27_1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/cncr.33323","article-title":"Defining the Role of Neoadjuvant Systemic Therapy in High\u2010Risk Retroperitoneal Sarcoma: A Multi\u2010Institutional Study From the Transatlantic Australasian Retroperitoneal Sarcoma Working Group","volume":"127","author":"Tseng W. W.","year":"2021","journal-title":"Cancer"},{"key":"e_1_2_10_28_1","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5395131","article-title":"Predictors of Disease\u2010Free and Overall Survival in Retroperitoneal Sarcomas: A Modern 16\u2010Year Multi\u2010Institutional Study From the United States Sarcoma Collaboration (USSC)","volume":"2019","author":"Schwartz P. B.","year":"2019","journal-title":"Sarcoma"},{"issue":"3","key":"e_1_2_10_29_1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/annonc\/mdt577","article-title":"Retroperitoneal Sarcomas: Patterns of Care at Diagnosis, Prognostic Factors and Focus on Main Histological Subtypes: A Multicenter Analysis of the French Sarcoma Group","volume":"25","author":"Toulmonde M.","year":"2014","journal-title":"Annals of Oncology"}],"container-title":["Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jso.70037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T09:55:16Z","timestamp":1758621316000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jso.70037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1002\/jso.70037"],"URL":"https:\/\/doi.org\/10.1002\/jso.70037","archive":["Portico"],"relation":{},"ISSN":["0022-4790","1096-9098"],"issn-type":[{"type":"print","value":"0022-4790"},{"type":"electronic","value":"1096-9098"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"2025-05-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}